Milestone Pharmaceuticals
MIST
28 hedge funds and large institutions have $133M invested in Milestone Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
16% more capital invested
Capital invested by funds: $114M → $133M (+$18.6M)
4% more funds holding
Funds holding: 27 → 28 (+1)
0.92% more ownership
Funds ownership: 66.85% → 67.77% (+0.92%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.74M |
| 2 |
BL
Bleichroeder LP
New York
|
+$1.5M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$486K |
| 4 |
EP
Eversept Partners
New York
|
+$201K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$42.3K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $7K | +$6.17K | +1,031 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $4K | +$2.44K | +408 | +278% |
|
28
Renaissance Technologies
New York
| – | -$151K | -26,400 | Closed |
|
29
Citadel Advisors
Miami,
Florida
| – | -$60K | -10,466 | Closed |
|
|
CFGS
30
Concourse Financial Group Securities
Birmingham,
Alabama
| – | -$1.47K | -245 | Closed |
|
MIST Hedge Fund Activity: Q4 2021 in Review
28 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q4 2021, worth a combined $133M — up 16% from $114M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MIST positions and 3 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.74M. The largest seller was Boxer Capital, cutting an estimated $2M.
- 28 institutional investors held Milestone Pharmaceuticals (MIST) as of Q4 2021, up from 27 in Q3 2021.
- Funds reported $133M of Milestone Pharmaceuticals stock for Q4 2021, up 16% quarter-over-quarter.
- 4 funds opened new Milestone Pharmaceuticals positions in Q4 2021 and 3 closed out, a net change of +1 holder.
- The largest Milestone Pharmaceuticals buyer in Q4 2021 was Millennium Management, an estimated $1.74M added.
- The largest Milestone Pharmaceuticals seller in Q4 2021 was Boxer Capital, an estimated $2M sold.
Based on aggregated 13F filings for Q4 2021.